ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | -100.0% | 150 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 150 | -72.0% | 0.00% | – |
| Q1 2021 | $2,000 | -66.7% | 535 | -72.4% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | 0.0% | 1,935 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | -14.3% | 1,935 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -66.7% | 1,935 | -45.2% | 0.00% | -50.0% |
| Q4 2019 | $21,000 | +40.0% | 3,533 | +82.6% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | -42.3% | 1,935 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $26,000 | +2500.0% | 1,935 | +1190.0% | 0.00% | – |
| Q1 2019 | $1,000 | -85.7% | 150 | -93.5% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | +600.0% | 2,311 | +1440.7% | 0.00% | – |
| Q3 2018 | $1,000 | -83.3% | 150 | -76.9% | 0.00% | -100.0% |
| Q3 2017 | $6,000 | -99.8% | 650 | +333.3% | 0.00% | +100.0% |
| Q2 2017 | $3,000,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |